| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 1995 | 9-substituted acridine derivatives with long half-life and potent antitumor activity: synthesis and structure-activity relationships. | Su, TL; Chou, TC; Kim, JY; Huang, JT; Ciszewska, G; Ren, WY; Otter, GM; Sirotnak, FM; Watanabe, KA | Journal of medicinal chemistry 38(17), 3226-3235 | | | |
| 2012 | A Combined DNA-Affinic Molecule and N-Mustard Alkylating Agent Has an Anti-Cancer Effect and Induces Autophagy in Oral Cancer Cells. | Lo, WL; Chu, PY; Lee, TH; Su, TL; Chien, Y; Chen, YW; Huang, PI; Tseng, LM; Tu, PH; Kao, SY; Lo, JF | International journal of molecular sciences 13(3), 3277-3290 | | | |
| 2016 | A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non-Small Cell Lung Cancer Cells. | Chen, CW; Wu, MH; Chen, YF; Yen, TY; Lin, YW; Chao, SH; Tala, S; Tsai, TH; Su, TL; Lee, TC | NEOPLASIA 18(4), 199-212 | | | |
| 1982 | Activity of 2-fluoro-5-methylarabinofuranosyluracil against mouse leukemias sensitive to and resistant to 1-beta-D-arabinofuranosylcytosine. | Burchenal, JH; Chou, TC; Lokys, L; Smith, RS; Watanabe, KA; Su, TL; Fox, JJ | Cancer research 42(7), 2598-600 | | | |
| 1988 | Anti-fertility and other actions of gossypol analogues. | Sonenberg, M; Huang, JT; Ren, YF; Su, TL; Watanabe, KA; Haspel, HC; Corin, RE; Hoffer, AP | Contraception 37(3), 247-255 | | | |
| 2002 | Antitumor AHMA linked to DNA minor groove binding agents: synthesis and biological evaluation. | Rastogi, K; Chang, JY; Pan, WY; Chen, CH; Chou, TC; Chen, LT; Su, TL | Journal of medicinal chemistry 45(20), 4485-4493 | | | |
| 2011 | Autophagy inhibition enhances apoptosis triggered by BO-1051, an N-mustard derivative, and involves the ATM signaling pathway. | Chen, LH; Loong, CC; Su, TL; Lee, YJ; Chu, PM; Tsai, ML; Tsai, PH; Tu, PH; Chi, CW; Lee, HC; Chiou, SH | Biochemical pharmacology 81(5), 594-605 | | | |
| 2009 | BO-0742, a derivative of AHMA and N-mustard, has selective toxicity to drug resistant leukemia cells and solid tumors | Lee, CH; Chou, TC; Su, TL; Yu, J; Shao, LE; Yu, AL. | Cancer Letters 276(2), 204-211 | | | |
| 2009 | BO-0742, a derivative of AHMA and N-mustard, has selective toxicity to drug sensitive and drug resistant leukemia cells and solid tumors. | Lee, CH; Chou, TC; Su, TL; Yu, J; Shao, LE; Yu, AL | Cancer letters 276(2), 204-11 | | | |
| 1988 | Chemical synthesis and biological activities of 5-deazaaminopterin analogues bearing substituent(s) at the 5- and/or 7-position(s). | Su, TL; Huang, JT; Chou, TC; Otter, GM; Sirotnak, FM; Watanabe, KA | Journal of medicinal chemistry 31(6), 1209-1215 | | | |
| 2010 | Combination of bifunctional alkylating agent and arsenic trioxide synergistically suppresses the growth of drug-resistant tumor cells. | Lee, PC; Kakadiya, R; Su, TL; Lee, TC | NEOPLASIA 12(5), 376-87 | | | |
| 1996 | Cyclopent[a]anthraquinones as DNA intercalating agents with covalent bond formation potential: synthesis and biological activity. | Kim, JY; Su, TL; Chou, TC; Koehler, B; Scarborough, A; Ouerfelli, O; Watanabe, KA | Journal of medicinal chemistry 39(14), 2812-2818 | | | |
| 2005 | Cytochrome C release induces apoptosis of nasopharyngeal carcinoma (NPC) by antitumor glyfoline. | Su, TL; Huang, HM; Wang, CK; Wu, HC; Lin, CT | Planta medica 71(1), 28-32 | | | |
| 2019 | Design and Synthesis of 1,2-Bis(hydroxymethyl)pyrrolo[2,1- a]phthalazine Hybrids as Potent Anticancer Agents that Inhibit Angiogenesis and Induce DNA Interstrand Cross-links. | Chang, SM; Jain, V; Chen, TL; Patel, AS; Pidugu, HB; Lin, YW; Wu, MH; Huang, JR; Wu, HC; Shah, A; Su, TL; Lee, TC | Journal of medicinal chemistry 62(5), 2404-2418 | | | |
| 2011 | Design, synthesis and antitumor evaluation of phenyl N-mustard-quinazoline conjugates. | Marvania, B; Lee, PC; Chaniyara, R; Dong, H; Suman, S; Kakadiya, R; Chou, TC; Lee, TC; Shah, A; Su, TL | Bioorganic & medicinal chemistry 19(6), 1987-1998 | | | |
| 2011 | Design, synthesis, and biological evaluation of novel water-soluble N-mustards as potential anticancer agents. | Kapuriya, N; Kakadiya, R; Dong, H; Kumar, A; Lee, PC; Zhang, X; Chou, TC; Lee, TC; Chen, CH; Lam, K; Marvania, B; Shah, A; Su, TL | BIOORGANIC & MEDICINAL CHEMISTRY 19(1), 471-485 | | | |
| 2013 | Determination of tissue distribution of potent antitumor agent ureidomustin (BO-1055) by HPLC and its pharmacokinetic application in rats. | Chien, SI; Yen, JC; Kakadiya, R; Chen, CH; Lee, TC; Su, TL; Tsai, TH | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 917-918, 62-70 | | | |
| 2002 | Development of DNA topoisomerase II-mediated anticancer agents, 3-(9-acridinylamino)-5-hydroxymethylanilines (AHMAs) and related compounds. | Su, TL | Current medicinal chemistry 9(18), 1677-1688 | | | |
| 2021 | Discovery of Oral Anticancer 1,2-Bis(hydroxymethyl)benzo[g]pyrrolo[2,1-a]phthalazine Hybrids That Inhibit Angiogenesis and Induce DNA Cross-Links | Chen, TL; Patel, AS; Jain, V; Kuppusamy, R; Lin, YW; Hou, MH; Su, TL; Lee, TC | Journal of Medicinal Chemistry 64(17), 12469-12486 | | | |
| 1983 | Distribution, metabolism, and excretion of 1-(2-fluoro-2-deoxy-beta-D- arabinofuranosyl)thymine and 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5- iodocytosine. | Philips, FS; Feinberg, A; Chou, TC; Vidal, PM; Su, TL; Watanabe, KA; Fox, JJ | Cancer research 43(8), 3619-27 | | | |
